Supplementary Data from Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk NeuroblastomaBalakrishna Koneru(Texas Tech University), C. Patrick Reynolds(University of Southern California)UnknownMarch 31, 202310.1158/0008-5472.22424632Cited by 0SaveCiteExport RISWatch citationsRelated PapersActivity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo|Blood|2007|155Characterization and Drug Resistance Patterns of Ewing's Sarcoma Family Tumor Cell Lines|PLoS ONE|2013|61